News
Midwest Allergy Sinus Asthma, SC
Dr. Siri’s 5-Minute Interview on Severe Asthma and Treatments (The Valder Beebe Show)
In an interview on The Valder Beebe Show, Dr. Siri discusses the clinical and patient experience aspects of severe asthma. Over two millions Americans of various ages live with severe asthma out of 20-30 million people with asthma. From 0:30 to 3:55, Dr. Siri...
A Drug Affordability Board Would Hurt Illinois Patients: Why Affordability Boards’ Current Approach Could Do More Harm Than Good
In a recent op-ed for the Springfield State Journal-Register "A drug affordability board would hurt Illinois patients", Dr. Dareen D. Siri shares a critical perspective on the proposed Prescription Drug Affordability Boards (PDABs) in Illinois. While the goal of...
CIIC Scholarship Call 2025
Deadline: March 21, 2025 Download CIIC Patient Scholarship Application 2025 : You can submit your application to your provider. CIIC Annual Patient Scholarship: Empowering PIDD and Rare Disease Patients The CIIC (Coalition of Immunology and Allergy Clinics) is proud...
New AD Cream for Adult Children 2 years and Older (tapinarof)
The U.S. Food and Drug Administration (FDA) has approved VTAMA® (tapinarof) cream, 1%, for the treatment of mild, moderate, or severe atopic dermatitis (AD) in adults and children aged 2 years and older. This approval expands the use of VTAMA, previously approved for...
What is D.R.E.S.S? (Drug Reaction with Eosinophilia and Systemic Symptoms)
Symptoms include fever, rash, facial swelling, enlarged lymph nodes and kidney or liver injury. Many drugs could cause D.R.E.S.S., but the most common drugs involved are specific types of antibiotics…
Non-steriodal cream treatment option approved by FDA for Atopic Dermatitis (Roflumilast cream)
The FDA approved Zoryve cream (0.15%) for mild to moderate atopic dermatitis this year for adults and children aged above 6 years old. Roflumilast cream (marketed under the name Zoryve) is a non-steroidal topical cream that is applied once daily to affected areas of...
FDA Greenlights Pemgarda for High-Risk COVID-19 Prevention
This is particularly important for the immunocompromised population, who are at greater risk of severe illness and have a diminished response to vaccines.
FDA approved chronic sinusitis medication without nasal polyps
US FDA approved of XHANCE as the first and only medication for adults with chronic rhinosinusitis without nasal polyps. It is a fluticasone propionate nasal spray which uses the Exhalation Delivery System to enable topical steroid to the inflamed areas and is proven effective.
CIIC Patient Scholarship Call 2024
CIIC Annual Patient Scholarship: Empowering PIDD and Rare Disease Patients The CIIC (Coalition of Immunology and Allergy Clinics) is proud to announce the continuation of its Annual Patient Scholarship program, initiated in 2021. This unique scholarship is...